tradingkey.logo
tradingkey.logo
Search

Gelteq Ltd

GELS
Add to Watchlist
0.580USD
-0.080-12.17%
Close 07/02, 13:00ETQuotes delayed by 15 min
6.21MMarket Cap
LossP/E TTM

More Details of Gelteq Ltd Company

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Gelteq Ltd Info

Ticker SymbolGELS
Company nameGelteq Ltd
IPO dateOct 29, 2024
CEOGivoni (Nathan Jacob)
Number of employees7
Security typeOrdinary Share
Fiscal year-endOct 29
AddressLevel 4
CityMELBOURNE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryAustralia
Postal code3205
Phone61390873990
Websitehttps://www.gelteq.com
Ticker SymbolGELS
IPO dateOct 29, 2024
CEOGivoni (Nathan Jacob)

Company Executives of Gelteq Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--

FAQs

Who are the top five shareholders of Gelteq Ltd?

The top five shareholders of Gelteq Ltd are: Mr. Nathan Jacob Givoni

How many institutions hold shares of Gelteq Ltd (GELS)?

As of 2026Q1, 9 institutions hold shares of Gelteq Ltd, with a combined market value of approximately 87.15K, accounting for 0.81% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -29363.00.